{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "72205-438",
      "generic_name": "DAPAGLIFLOZIN AND SAXAGLIPTIN",
      "labeler_name": "Novadoz Pharmaceuticals LLC",
      "brand_name": "DAPAGLIFLOZIN AND SAXAGLIPTIN",
      "active_ingredients": [
        {
          "name": "DAPAGLIFLOZIN",
          "strength": "10 mg/1"
        },
        {
          "name": "SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE",
          "strength": "5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "72205-438-01",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (72205-438-01)",
          "marketing_start_date": "20260409",
          "sample": false
        },
        {
          "package_ndc": "72205-438-02",
          "description": "90 TABLET, FILM COATED in 1 BOTTLE (72205-438-02)",
          "marketing_start_date": "20260409",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Novadoz Pharmaceuticals LLC"
        ],
        "rxcui": [
          "1925498"
        ],
        "spl_set_id": [
          "1cfa51fd-8406-404c-b2a8-0fc1068675fb"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0372205438026",
          "0372205438019"
        ],
        "nui": [
          "N0000187059",
          "N0000187058"
        ],
        "pharm_class_epc": [
          "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
        ],
        "unii": [
          "1ULL0QJ8UC",
          "4N19ON48ZN"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "1cfa51fd-8406-404c-b2a8-0fc1068675fb",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260406",
      "product_id": "72205-438_1cfa51fd-8406-404c-b2a8-0fc1068675fb",
      "application_number": "ANDA211533",
      "brand_name_base": "DAPAGLIFLOZIN AND SAXAGLIPTIN",
      "pharm_class": [
        "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
        "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}